CB
CeriBell, Inc.
CBLL · NASDAQ
$23.63 +0.90% (+$0.21)
1M +1.63%
Market Cap $932.3M
P/E Ratio -
Div. Yield -
ROE 44.85%
Piotroski F-Score Weak
2/9Valuation
5 /100
Expensive P/S 9.14x
P/B 7.27x
P/E N/A
Growth
100 /100
Growing Rev. growth 50.90%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 88.90%
Net margin 64.73%
Op. margin 68.62%
Quality
8 /100
Poor ROIC 46.54%
ROE 44.85%
ROA 39.67%
Debt
69 /100
Low Debt/Equity 0.17x
Current ratio 9.18x
Int. coverage -35.38x
Stability
42 /100
Moderate Beta 0.81x
Rev. volatility 20.13%
EPS volatility 121.38%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na CBLL
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Xingjuan Chao
Employees
327
Headquarters
Sunnyvale
Nadcházející události
03 LIS
Earnings
Upcoming earnings report